Our PS2025Speakers
PS2025 will feature hundreds of speakers from across the world exploring the full spectrum of psychedelics, including science, medicine, policy, business, spirituality, and culture in 14 tracks, making this one of the largest Psychedelic Science gatherings ever.
Programming Tracks
Big ideas and high-profile speakers exploring the integration of psychedelics into broader society and culture.
A half-day series on ways plant medicine can support Black communities in healing from systemic and interpersonal racism, trauma, and exploitation.
The infrastructure for scaling safe and responsible access to psychedelics, including finance, drug development, regulatory, clinics and service centers, technology, and community institutions.
Dialogues and stories about psychedelics from the perspectives of unique and intersectional communities.
The latest insights on the neuroscience, pharmacology, and chemistry of psychedelics, and the quest to understand their mechanisms of action.
A single-day forum focused on the new systems of state-regulated access to psychedelic experiences in Colorado and Oregon.
A single-day forum for veterans, first responders, and their families about the growing movement to bring psychedelic healing to their communities.
Personal selections from MAPS Founder Rick Doblin, focusing on the living legacy and pioneers of psychedelic research, therapy, and culture.
The world of ethnobotanical practices that use psychedelic plant medicines, including Indigenous, traditional, spiritual, and contemporary approaches.
The legislative, judicial, and regulatory foundations required to create and manage safe and responsible access to psychedelics and a post-prohibition society.
The intersection of psychedelics and society, including popular culture, the arts and music, media, religion and spirituality, ethnicity and culture, and the psychedelic community itself.
New research spanning a variety of fields, including clinical trials, naturalistic use, risk & safety, public opinion, health and wellness, religion & spirituality, and global culture.
Findings and updates from clinical trials studying the potential of psychedelics in the treatment of serious mental illness and neurological disorders.
Deep discussions for clinicians and facilitators from intake to integration, including critical viewpoints on evidence-based practices, education and training, ethics and accountability, and the delivery of care.
Confirmed Speakers
AZA Allsop
Abigail Calder
Adam Marr
Alan Davis
Alex Horton
Alina Tiemroth
Alkyoni Athanasiou-Fragkouli
Allison Wilson
Amber Capone
Amy Emerson
Amy Lehrner
Amy McGuire
Andrea Gomez
Andrea Venezia
Andrew Penn
Angela Allbee
Anne Wagner
AnneClaire Stapleton
Anthony Back
Ariel Clark
Balázs Szigeti
Ben Kelmendi
Bessel van der Kolk
Betty Aldworth
Bia Labate
Brandon Weiss
Cat Packer
Chris Stauffer
Christine Caldwell
Christine Diindiisi McCleave
Courtney Watson
Dan Grossman
Danielle Herrera
David Nutt
Deidra Somerville
Devon Phillips
Diane Goldstein
Diego Ugalde
Doug Drysdale
Draulio Araujo
Edward Jacobs
Emmanuelle Schindler
Ethan Goldwater
Fadel Zeidan
Fayzan Rab
Gabrielle Agin-Liebes
Gisele Fernandes-Osterhold
Gokul Raj
Grace Cepe
Hanifa Nayo Washington
Hannah Hetzer
Harriet de Wit
Heidi Allen
Heidi Pendergast
Irina Alexander
Ismail Ali
Jamila Hokanson
Jason Luoma
Jason Ortiz
Jay Michaelson
Jaz Cadoch
Jesse Gould
Jessica Nielson
Joanna Kuc
Joseph McCowan
Josh Hardman
Justin LaPree
Kat Murti
Kelley O'Donnell
Kenneth Shinozuka
Kenneth Tupper
Kevin Balktick
Kevin Cranford
Kufikiri Imara
Kyrsten Sinema
Leor Roseman
Lia Mix
Liana Gillooly
Marcela Ot'alora
Marina Bolser
Mark Rasenick
Matthew Lowe
Matthew Wall
Melissa Whippo
Mia Sarno
Miriam Volat
Mitchell Gomez
Monnica Williams
Natalie Ginsberg
Natalie Gukasyan
Pamela Roundtree
Parsa Yousefi
Paul Liknaitzky
Paul Stamets
.jpg)
Pilar Guzmán
Rachel Simon
Richard Schwartz
Rick Doblin
Robin Carhart-Harris
Roman Haferd
